Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00831
|
|||||
Drug Name |
Gamma-aminobutyric acid
|
|||||
Synonyms |
1956/12/2; 3-Carboxypropylamine; 4-Aminobutanoic acid; 4-amino-butanoic acid; 4-aminobutyrate; 4-aminobutyric acid; Aminalon; Butyric acid, 4-amino-; GABA; GAMMA-AMINO-BUTANOIC ACID; Gaballon; Gamarex; Gamastan; Gammagee; Gammalon; Gammalone; Gammar; Gammasol; Gamulin; Immu-G; Mielogen; Mielomade; Piperidic acid; Piperidinic acid; Reanal; butanoic acid, 4-amino-; gamma-Amino butyric acid; gamma-Aminobutanoic acid; gamma-Aminobuttersaeure; gamma-Aminobutyric acid; gamma-amino-n-butyric acid; gamma-aminobutyric acid; omega-Aminobutyric acid
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Inflammatory bowel disease [ICD11: DD7Z] | Phase 1/2 | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C4H9NO2
|
|||||
Canonical SMILES |
C(CC(=O)O)CN
|
|||||
InChI |
InChI=1S/C4H9NO2/c5-3-1-2-4(6)7/h1-3,5H2,(H,6,7)
|
|||||
InChIKey |
BTCSSZJGUNDROE-UHFFFAOYSA-N
|
|||||
CAS Number |
CAS 56-12-2
|
|||||
Pharmaceutical Properties | Molecular Weight | 103.12 | Topological Polar Surface Area | 63.3 | ||
Heavy Atom Count | 7 | Rotatable Bond Count | 3 | |||
Hydrogen Bond Donor Count | 2 | Hydrogen Bond Acceptor Count | 3 | |||
XLogP |
-3.2
|
|||||
PubChem CID | ||||||
ChEBI ID |
CHEBI:16865
|
|||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | GABT1 | Transporter Info | Sodium- and chloride-dependent GABA transporter 1 | Substrate | [2] | |
VIAAT | Transporter Info | Vesicular inhibitory amino acid transporter | Substrate | [3] | ||
References | ||||||
1 | Emerging drugs to treat Crohn's disease. Expert Opin Emerg Drugs. 2007 Mar;12(1):49-59. | |||||
2 | Mutations in the GABA Transporter SLC6A1 Cause Epilepsy with Myoclonic-Atonic Seizures. Am J Hum Genet. 2015 May 7;96(5):808-15. | |||||
3 | Wakefulness Is Governed by GABA and Histamine Cotransmission. Neuron. 2015 Jul 1;87(1):164-78. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.